Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

OBJECTIVES: Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options. METHODS: Paired reviewe...

Descripción completa

Detalles Bibliográficos
Autores principales: González-González, José Gerardo, Díaz González-Colmenero, Alejandro, Millán-Alanís, Juan Manuel, Lytvyn, Lyubov, Solis, Ricardo Cesar, Mustafa, Reem A, Palmer, Suetonia C, Li, Sheyu, Hao, Qiukui, Alvarez-Villalobos, Neri Alejandro, Vandvik, Per Olav, Rodríguez-Gutiérrez, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273479/
https://www.ncbi.nlm.nih.gov/pubmed/34244276
http://dx.doi.org/10.1136/bmjopen-2021-049130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273479/
https://www.ncbi.nlm.nih.gov/pubmed/34244276
http://dx.doi.org/10.1136/bmjopen-2021-049130

Ejemplares similares